Telomere length attrition, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian males with type 2 diabetes mellitus by Harte, Alison L. et al.
 University of Warwick institutional repository: http://go.warwick.ac.uk/wrap 
 
This paper is made available online in accordance with 
publisher policies. Please scroll down to view the document 
itself. Please refer to the repository record for this item and our 
policy information available from the repository home page for 
further information.  
To see the final version of this paper please visit the publisher’s website. 
Access to the published version may require a subscription. 
Author(s):  Alison L. Harte, Nancy F. da Silva, Michelle A. Miller, 
Francesco P. Cappuccio, Ann Kelly, Joseph P. O’Hare, Anthony H. 
Barnett, Nasser M. Al-Daghri, Omar Al-Attas, Majed Alokail, Shaun 
Sabico, Gyanendra Tripathi, Srikanth Bellary, Sudhesh Kumar, and 
Philip G. McTernan 
Article Title: Telomere Length Attrition, a Marker of Biological 
Senescence, Is Inversely Correlated with Triglycerides and Cholesterol 
in South Asian Males with Type 2 Diabetes Mellitus 
Year of publication: 2012 
Link to published article:  
http;//dx.doi.org/10.1155/2012/895185 
Publisher statement:  Copyright © 2012 Alison L. Harte et al. This is an 
open access article distributed under the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly 
cited. 
 
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2012, Article ID 895185, 7 pages
doi:10.1155/2012/895185
Research Article
Telomere Length Attrition, a Marker of Biological Senescence,
Is Inversely Correlated with Triglycerides and Cholesterol in
South Asian Males with Type 2 Diabetes Mellitus
Alison L. Harte,1 Nancy F. da Silva,1, 2 Michelle A. Miller,1 Francesco P. Cappuccio,1
Ann Kelly,3 Joseph P. O’Hare,1 Anthony H. Barnett,3 Nasser M. Al-Daghri,4, 5
Omar Al-Attas,4, 5 Majed Alokail,4, 5 Shaun Sabico,4 Gyanendra Tripathi,1 Srikanth Bellary,3, 6
Sudhesh Kumar,1 and Philip G. McTernan1
1Clinical Sciences Research Laboratories, Division of Metabolic and Vascular Health, Warwick Medical School, University of Warwick,
University Hospital Coventry and Warwickshire, Coventry CV2 2DX, UK
2AstraZeneca R&D, CVGI Bioscience, Mereside, Alderley Park, Macclesfield, Chesire SK1 04TG, UK
3University of Birmingham and Biomedical Research Centre, Heart of England NHS Foundation Trust, Birmingham B4 7ET, UK
4Biomarkers Research Program, Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
5Center of Excellence in Biotechnology, King Saud University, Riyadh 11451, Saudi Arabia
6Aston University, Birmingham B4 7ET, UK
Correspondence should be addressed to Philip G. McTernan, p.g.mcternan@warwick.ac.uk
Received 17 September 2011; Revised 14 November 2011; Accepted 21 November 2011
Academic Editor: Toshiyasu Sasaoka
Copyright © 2012 Alison L. Harte et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
South Asians have a higher risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) than white Caucasians, for
a given BMI. Premature biological ageing, assessed by reduction in telomere length (TL), may be mediated by factors resulting
from altered metabolic profiles associated with obesity. We hypothesise that ethnicity and metabolic status represent detrimental
factors contributing to premature biological ageing. Therefore we assessed TL in two South Asian, age and BMI-matched cohorts
[T2DM (n = 142) versus non-T2DM (n = 76)] to determine the eﬀects of BMI, gender, lipid and CVD profile on biological
ageing. Genomic DNA was obtained from the UKADS cohort; biochemical and anthropometric data was collected and TL was
measured by quantitative real-time PCR. Our findings indicated a gender-specific eﬀect with reduced TL in T2DM men compared
with non-T2DMmen (P = 0.006). Additionally, in T2DMmen, TL was inversely correlated with triglycerides and total cholesterol
(r = −0.419, P < 0.01; r = −0.443, P < 0.01). In summary, TL was reduced amongst South Asian T2DM men and correlated
with triglycerides and total cholesterol. This study highlights enhanced biological ageing among South Asian, T2DM men, which
appears to be tracked by changes in lipids and BMI, suggesting that raised lipids and BMI may directly contribute to premature
ageing.
1. Introduction
People of South Asian origin have a higher predisposition
to the development of obesity-related diseases, including
type 2 diabetes mellitus (T2DM) when compared with white
Caucasians and other ethnicities [1, 2]. Increased metabolic
risk among South Asians has been linked to significantly
higher leptin levels when compared to other ethnic groups
and leptin is a predictor for cardiovascular risk and T2DM.
Heightened leptin levels in South Asians may be due to the
higher body fat percentage, with more pronounced abdom-
inal obesity compared with other ethnic groups matched for
the same body mass index (BMI). This unfavourable body
composition promotes decreased insulin sensitivity in this
racial group [3]. Dyslipidaemia, specifically low high-density
lipoprotein cholesterol (HDL-cholesterol), is also more com-
mon among South Asians compared with Europeans and
East Asians [4]. These diﬀerences in metabolic phenotypes
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shed light on ethnic discrepancies in risk assessment and
support the need for customized screening and diagnosis to
optimize treatment. We have previously demonstrated that
culturally tailored diabetes care among South Asians leads
to enhanced health outcomes as compared to conventional
standard care [5].
Telomere length (TL) may play an important role in un-
derstanding premature ageing due to the influences of met-
abolic parameters across ethnic groups. Telomeres are tan-
dem repeats of DNA sequences (TTAGGG) at the end of
chromosomes that play an important part in the biology
of eukaryotic cells [6], a role as biomarkers of senescence
and ageing has been established in many studies, with TL
decreasing with advancing age [7–9]. Furthermore, ethnic
differences in TL have been observed in diﬀerent ethnic
groups, with black Afro-Caribbean and Hispanic ethnic
groups showing greater diﬀerences in age-associated TL than
white Caucasians [10]. TL has also been associated with
many modifiable factors such as lifestyle and marital status
[11, 12]. More importantly, there is a significant influence of
age-related diseases such as coronary heart disease (CHD),
T2DM and cancer on TL reduction [13–16].
Several studies confirm the presence of shorter TL among
various ethnicities in patients with T2DM and insulin resist-
ance [15, 17]. To our knowledge, no study has reported data
on South Asians with respect to TL and metabolic state.
Our cross-sectional study aims to determine whether
premature biological ageing, assessed by reduction in TL, is
evident in a cohort phenotypically predisposed to develop in-
sulin resistance. Specifically, we aim to identify associations
between TL and BMI, gender, lipid, and cardiovascular pro-
file in both T2DM and non-T2DM South Asians.
2. Materials and Methods
2.1. Subjects. Age- and BMI-matched T2DM and subjects,
aged between 45–60 years old, were randomly selected from
the UK Asian Diabetes Study (UKADS, T2DM) [18, 19] and
from the Wandsworth Heart and Stroke Study (WHSS, non-
T2DM) [20, 21]. The selection of the age range was utilized
to ensure suﬃcient power for the study and based on the UK
Prospective Diabetes Study (UKPDS) population matching
the non-T2DM cohort. Biochemical and anthropometric
data were collected for T2DM and non-T2DM subjects,
which are detailed in tables 1 and 2. Routine T2DM man-
agement, dietary intervention, first line therapy (metformin
and combination fibrates), as deemed clinically appropriate,
were implemented.
2.2. UKADS and WHSS Plasma and Genomic DNA Extrac-
tion. Venous blood (2 × 9mL) per subject was collected in
EDTA-coated vacutainers and allowed to stand upright at
4◦C overnight. Plasma (1mL) was removed from each tube
and stored at −80◦C until required. The remaining blood
samples were used for DNA extraction. Genomic DNA was
extracted using an adaptation of the Nucleon BACC2 proto-
col (GE Healthcare, Little Chalfont, Buckinghamshire, UK).
The DNA was resuspended in 200 µL of TE buﬀer (10mM
Tris, 0.1mM EDTA, pH 8) and quantified by fluorometry
using PicoGreen dye (Invitrogen-Molecular Probes, Paisley,
UK) as well as by spectrophotometry, using the Nanodrop
ND-1000 (NanoDrop Technologies, Wilmington, DE, USA).
2.3. TL Measurement. TL was measured by quantitative real-
time polymerase chain reaction (RT-PCR) using the iQCy-
cler real-time PCR system (Bio-Rad Laboratories, Hercules,
CA, USA) [22]. In brief, TL was measured using the follow-
ing telomere primers: primer Tel1b (5′ CGGTTTGTTTGG-
GTTTGGGTTTGGGTTTGGGTTTGGGTT 3′, 450 nM),
Tel2b (5′ GGCTTGCCTACCCTTACCCTTACCCTTACC-
CTTACCCT 3′, 450 nM primer), 10 ng genomic DNA, 2xiQ
SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA,
USA) in a 30 µL reaction. The reactions were set up in
quadruplicate in 96-well plates non-T2DM subjects. For each
plate four DNA quantity standards (serial dilution ranging
from 15 and 1.87 ng per 30 µL reaction) and three TL stan-
dards were also analysed. The three TL standards included
15 ng of genomic DNA from isogenic human thyroid-derived
cell lines: K1E72 (TL 3110 bp) and K1E71 (TL 3440 bp) and
from a human lung fibroblast cell line MRC5 (TL 8470 bp).
Standard curves were derived to convert the threshold cycle
number (ΔCT) into starting quantity (SQ) of DNA and to
convert the telomere/single copy gene SQ ratio to TL in
base pairs (bp) [21–23]. The PCR cycle conditions were as
follows: 95◦C for 3min, 40 cycles of 95◦C for 15 s and 56◦C
for 60 s. In order to confirm the PCR specificity, a melting
curve (dissociation curve) was performed by 46 repeats of
increasing temperature, as previously described [22]. TL is
expressed as mean ± standard deviation (SD).
2.4. Measurement of Insulin, Glucose, and Lipid Profile Levels.
Plasma samples were analyzed for determination of insulin
protein concentrations by a solid phase enzyme linked im-
munosorbant assay (Linco Research Inc. Missouri, USA; In-
sulin CV intraassay 5.96%, interassay 10.3 ± 0.9%). Glucose
concentration was determined by a glucose oxidase meth-
od (YSI 200 STAT Plus, YSI Incorporated, Yellow Springs,
OH, USA). Lipid profile was measured by the Clinical
Biochemistry Laboratory at the University of Birmingham/
Heartlands/Queen Elizabeth Hospitals.
2.5. Statistical Analysis. Linear regressions, graphical func-
tions, intergroup comparisons and Pearson’s correlations
were performed using the Statistical Package for the Social
Sciences software (SPSS version 14.0 SPSS Inc., Chicago, IL,
USA). TL and triglyceride data displayed a non-Gaussian
distribution; therefore both data sets were accordingly log
transformed prior to analysis. TL is represented by mean ±
SD and adjusted for age.
3. Results
TL in subjects with T2DM. The general characteristics of
both groups were presented in Tables 1 and 2. Mean TL for
T2DM South Asian subjects was 5811.03± 1945.52 bp (log10
TL: 3.74± 0.13). We also examined TL for gender diﬀerences
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Table 1: General characteristics of the T2DM group (UKADS).
United Kingdom Asian Diabetes study
All Females Males P value
N 142 86 56
Age (years) 53.6± 5.8 53.8± 6.1 53.2± 5.5 NS
BMI (kg/m2) 28.4± 4.9 30.1± 5.1 26.4± 3.8 NS
Glucose (mmol/L) 5.6± 0.5 5.3± 0.6 5.9± 0.7 NS
Insulin (µU/mL) 29.9± 2.3 30.3± 3.4 29.4± 3.0 NS
Total cholesterol (mmol/L) 4.7± 0.1 4.8± 0.2 4.7± 0.1 NS
HDL-cholesterol (mmol/L) 1.1± 0.02 1.2± 0.03 1.05± 0.03 0.0001
LDL-cholesterol (mmol/L) 2.4± 0.10 2.4± 0.1 2.5± 0.2 NS
Triglycerides (mmol/L) 2.8± 0.2 2.7± 0.2 2.95± 0.2 NS
Waist circumference (cm) 101.7± 12.3 97.2± 12.7 105.8± 10.4 0.00002
Systolic BP (mmHg) 136± 20.0 135± 16.0 137± 22.0 NS
Diastolic BP (mmHg) 83± 10.0 83± 10.0 83± 11.0 NS
CHD risk (at 10 years %) 13.3± 6.0 14.5± 5.4 12.1± 6.1 NS
Note: NS: nonsignificant; CHD: cardiovascular heart disease.
Table 2: General characteristics of non-T2DM subjects (WHSS).
Wandsworth Heart and Stroke study
All Females Males P value
N 76 33 43
Age (years) 49.81± 5.23 49.67± 5.27 49.93± 5.26 NS
BMI (kg/m2) 25.74± 3.61 27.53± 3.90 24.38± 2.67 NS
Note: NS, nonsignificant.
and noted that males had a mean TL of 6040.64±2004, 37 bp
(log10 TL: 3.76±0.11) while females had 5608.61±1882.12 bp
(log10 TL : 3.73 ± 0.14). TL did not display gender dimor-
phism in T2DM South Asian subjects (P =NS). Age and BMI
adjusted comparisons revealed that male T2DM subjects had
significantly reduced TL compared with their non-T2DM
counterparts (P = 0.008 (log10 TL), Figure 1(a)). This
diﬀerence was not observed in the female cohort. Mean TL
of T2DM was significantly reduced as compared with non-
T2DM South Asians (P = 0.009 (log10 TL), (Figure 1(b)).
3.1. Lipid Profile and TL in South Asian T2DM Subjects.
Given that T2DM was associated with a reduction in TL in
South Asians, further analysis investigated whether altered
lipid profile had an eﬀect on TL. Total cholesterol, LDL-
cholesterol, and triglycerides showed no gender diﬀerences
(Table 1), but HDL-cholesterol was significantly higher in
females compared to males (P = 0.0001 Table 1). There
was no relationship overall between the lipid profiles for
the T2DM group (Figures 2(a) and 3(a), data not shown,
resp.), but when the cohort was stratified by gender, total
cholesterol was inversely associated with TL in T2DM males,
even after adjusting for age (r = −0.414, P = 0.001; age
adjusted: r = −0.419, P = 0.0018). Triglycerides showed a
similar pattern, demonstrating an inverse association with
age-adjusted TL of T2DM males (r = −0.355, P = 0.008;
age adjusted: r = −0.386, P = 0.007). These associations
were not observed in the female group (Figures 2(b) and
3(b)). Further subgroup analysis, according to BMI, in the
male cohort highlighted that in obese subjects triglycerides
inversely correlated with TL (r = −0.336, P = 0.038; age
adjusted: r = −0.388, P = 0.016; n = 39; Figure 4). The rest
of the associations were noncontributory with no significant
eﬀects noted by the use of medication.
4. Discussion
In our study, reduced telomere length (TL) observed in
T2DM South Asian males was inversely associated with total
cholesterol and triglycerides, even after adjusting for con-
founders. Shortened TL in T2DM subjects has previously
been observed in Afro-Caribbeans [14], Arabs [15], and Cau-
casian subjects [17]. Information regarding TL and T2DM
among South Asians is scarce, although in this population
shortened TL has been observed for other age-related diseas-
es, especially in vascular diseases (coronary artery disease)
and hypertension, and cancer [13, 23, 24]. We observed
that non-T2DM male subjects had, on average, shorter TL
than non-T2DM females, confirming gender dimorphism
which was also observed in other ethnic groups (Europeans,
Japanese, as well as Arab children) [25–27]. The nonsignif-
icant associations of TL to other parameters in this study,
such as age, BMI and waist circumference, do not supersede
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Figure 1: (a) Gender distribution of telomere length (TL) in peripheral blood mononuclear cells in South Asian non-T2DM (male: dark
circles, females: open circles) and T2DM (male: dark squares, females: open squares); (b) TL in peripheral blood mononuclear cells in South
Asian non-T2DM (circles) and T2DM (squares). TL is represented as mean (dotted line) ± SD, ∗P < 0.05 and ∗∗P < 0.01.
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Figure 2: The relationship between total cholesterol and TL in South Asian T2DM group. (a) Linear regression analysis of total cholesterol
and TL in T2DM (clear triangles); (b) linear regression analysis of total cholesterol and TL in T2DM by gender (male: dark squares and solid
line, females: open squares and dotted line).
prior findings associating TL to age and obesity [15, 27, 28],
since it is most likely that the present study’s cohort did
not reach enough power to elicit significance, or possibly
due to the wide range of interindividual variation of TL
[27].
The exact mechanism of TL attrition among patients
with T2DM is largely explained by insulin resistance, a meta-
bolic condition that promotes reactive oxygen species (ROS)
formation and favours a proinflammatorymilieu, two factors
known to reduce lifespan [29]. One of the most important
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Figure 3: The relationship between triglycerides and TL in South Asian T2DM group. (a) Linear regression analysis of triglycerides and
TL in T2DM (clear triangles); (b) linear regression analysis of triglycerides and TL in T2DM by gender (male: dark squares and solid line,
females: open squares and dotted line).
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Figure 4: TL in obese male T2DM subjects (BMI: 25–34.9 kg/m2)
is inversely correlated with triglycerides (N = 39).
pathways in the regulation of longevity appears to be en-
docrine signalling—many mutations that extend lifespan in
animal studies involve homologues of insulin and insulin-
like growth factor signalling, genes that were observed to ex-
tend lifespan by up to 6-fold in model studies [30, 31].
Several hypotheses explain the gender diﬀerence in TL
amongst non-T2DM subjects in this study. First is the high-
er stress exposure for males and the protective eﬀect of oe-
strogen in females. Males are more vulnerable to acute and
chronic stress in animal models, as well as in lower occupa-
tional class workers, compared with females who are more
sensitive to stress but nevertheless more resilient [32, 33].
The presence of chronic psychological stress in modern-day
adults is, in part, related to a fast-paced modern lifestyle,
which significantly contributes to obesity and dysmetabolic
syndrome-related ageing, as it can lead to overeating. Fur-
thermore, coelevation of cortisol and insulin causes accumu-
lation of visceral fat over time, which harbours a biochemical
environment conducive to several ageing mechanisms that
lead to cell senescence [28, 34]. Benetos and colleagues fur-
ther explained that at any given chronological age, biological
ageing is more advanced in men compared to women, since
only in men was TL observed to influence pulse pressure, an
index of arterial ageing, hence the conclusion that arterial
ageing is modified by gender [35]. In addition, oestrogen de-
ficiency has been shown, in animal models, to inhibit telom-
erase and, ultimately, lead to telomere shortening [36, 37].
Considering that most, if not all, T2DM women involved
in this study were postmenopausal, the protective eﬀects of
oestrogen are lost and therefore women, at this stage, tend to
catch up with men in the expression of age-related diseases,
including telomere attrition.
The significant inverse association of TL with several key
lipid parameters (total cholesterol and triglycerides) in South
Asian men strengthens the premise that biological ageing
is heightened in males, as compared with females of the
same chronological age [35]. Diﬀerences in triglycerides and
HDL-cholesterol between South Asian men and women
have also been documented [38], with higher CHD risk for
South Asian men as compared to African-Caribbean, white
Europeans, and African and Hispanic Americans [39, 40].
The increased predisposition of South Asians to age-related
chronic diseases is attributed not only to genetic suscepti-
bility, but also to diﬀerences in fat deposition, high physical
inactivity and diﬀerences in diet [40–42].
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The atherogenic properties of elevated cholesterol and
triglycerides confer repeated mechanical, hemodynamic,
and/or immunological injury and, as such, may cause aug-
mented cell turnover and increased production of ROS in
certain cells [28]. The link between cholesterol and TL may
be secondary to increased cell damage and turnover, which in
turn amplifies cell ageing by bringing cells to their maximum
replicative capacity—translating to shortened TL. This could
also tie in with age-related innate immune pathway activa-
tion in adipose tissue and its link with subclinical chronic
inflammation [15].
This study has several limitations. Causality cannot be
inferred from this work due to the cross-sectional nature
of the study. Furthermore, while most of our findings are
confirmatory, it is noteworthy that South Asians are unique
compared to other ethnicities, as several factors that include
gender discrepancy and metabolic parameters (such as total
cholesterol and triglycerides) appear to play a role in the
complex maintenance of TL. These observations were either
noted in both genders in other ethnic groups or not at all.
In summary, male South Asians with T2DM have shorter
TL when compared with their non-T2DM counterparts, and
this correlates with triglycerides and cholesterol levels in the
same subgroup. This study highlights enhanced biological
ageing among South Asian T2DM men, which appears to
be tracked by changes in lipids and BMI. This suggests that
raised lipids and BMI could directly contribute to premature
ageing; however, this possibility needs further study.
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